Rocket Lab (RKLB) Stock Could Be 28.5% Overvalued After Its Strong Run

Rocket Lab

Rocket Lab

RKLB

0.00

Recent Price Moves Put Rocket Lab Stock in Focus

Rocket Lab (RKLB) stock has swung sharply, with a gain over the past 3 months and a large 1-year total return, even as the share price declined over the past month.

At a share price of $109.25, Rocket Lab has seen short term share price momentum fade with a 30 day share price return of down 12.44%, even as longer term total shareholder returns have been very strong.

If you are looking beyond Rocket Lab for other space and advanced technology plays, this is a good moment to review 32 robotics and automation stocks

With Rocket Lab stock posting a very large 1 year total return, but trading slightly above the average analyst price target and at a discount to some intrinsic value estimates, should you view this as a potential mispricing, or are markets already factoring in expectations for future growth?

Most Popular Narrative: 28.5% Overvalued

According to the most followed Rocket Lab narrative, a fair value of $85.04 sits well below the recent $109.25 share price, which sets up a clear valuation gap for investors to assess.

Rocket Lab is mid transformation from a small launch specialist into a vertically integrated space and defense prime, with Space Systems now ~67% of revenue and growing fastest.

A $1.85b backlog (+73% YoY) anchored by the $816m SDA Tranche 3 award provides multi-year revenue visibility that the current trailing P/S of ~72x does not yet fully reflect.

Curious what revenue path, margin profile and future cash flows are being used to justify that fair value for Rocket Lab stock? The narrative highlights a specific growth ramp, a detailed margin uplift from vertical integration and a future valuation multiple usually reserved for established aerospace leaders. Want to see how those moving parts combine into one price tag? Read on to see the full reasoning behind this valuation call.

Result: Fair Value of $85.04 (OVERVALUED)

However, Rocket Lab faces real pressure points, including execution risk around the Neutron launch timeline and reliance on large defense contracts that could shift or be delayed.

Next Steps

With mixed views around Rocket Lab's risks and rewards, do you want to rely on others or test the thesis yourself? Take a closer look at the balance of concerns and potential upsides by reviewing the 1 key reward and 3 important warning signs

Looking for more investment ideas beyond Rocket Lab stock?

If you stop with Rocket Lab, you miss a wider field of opportunities. Use the Simply Wall St Screener to quickly surface stocks that fit your style.

  • Target potential turnaround stories with solid business foundations by reviewing the screener containing 20 high quality undiscovered gems that might not be on every investor's radar yet.
  • Sharpen your focus on resilience by scanning the 68 resilient stocks with low risk scores that score well on stability and downside protection.
  • Strengthen the quality of your watchlist by filtering for the solid balance sheet and fundamentals stocks screener (48 results) that can better handle shocks and funding needs.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.